Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Sees Large Drop in Short Interest

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) saw a large decline in short interest in February. As of February 15th, there was short interest totalling 1,600 shares, a decline of 97.5% from the January 31st total of 65,000 shares. Based on an average trading volume of 440,900 shares, the days-to-cover ratio is currently 0.0 days.

Daiichi Sankyo Stock Up 2.4 %

Shares of DSNKY traded up $0.56 during trading hours on Thursday, reaching $23.58. The company’s stock had a trading volume of 211,780 shares, compared to its average volume of 227,494. The firm has a market cap of $45.00 billion and a price-to-earnings ratio of 27.42. The company has a quick ratio of 2.11, a current ratio of 2.77 and a debt-to-equity ratio of 0.06. The company has a 50 day moving average of $26.32 and a two-hundred day moving average of $31.27. Daiichi Sankyo has a 1-year low of $22.47 and a 1-year high of $42.48.

Daiichi Sankyo (OTCMKTS:DSNKY) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. As a group, research analysts predict that Daiichi Sankyo will post 0.73 EPS for the current fiscal year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.